An online marketplace for outsourced biotech research is incorporating a blockchain platform to build a more robust system.
Scientist.com confirmed this week it is launching DataSmartTM to ensure users can be confident of the integrity of the data and information provided.
Chris Petersen, CTO and Founder, said: “Blockchain’s ability to ensure the integrity of information is the basis of its use in cryptocurrencies. In biopharma research we need blockchain technology to verify and validate the supply chain and to ensure the integrity of research data. Our new DataSmartTM platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered.”
The issue of security in biotech was discussed by Professor Jean Peccoud, Abell Chair in synthetic biology at Colorado State University, in our biotech special edition published earlier this year – check it out below.